Skip to main content

Is IgA Nephropathy (IgAN) a Familial or Sporadic Disease?

  • Chapter
  • First Online:
Pathogenesis and Treatment in IgA Nephropathy

Abstract

There have been several lines of evidences for familial aggregation of IgA nephropathy (IgAN), as well as mesangial deposition of IgA, suggesting that the susceptibility to this disease is genetically controlled. In our institute, family histories of hematuria, end-stage kidney disease, and glomerulonephritis are observed in about 10 % of cases with IgAN, even in those without any significant hereditary nephritis or kidney diseases. Recent large-scale genome-wide association studies (GWAS) of sporadic IgAN have identified multiple susceptibility loci, providing an insight into the genetic architecture of this disease, although each of their individual impact to the development of the disease is still not enough. It has been recognized that most of these loci are either directly associated with risk of inflammatory bowel disease (IBD) or maintenance of the intestinal epithelial barrier and response to mucosal pathogens. Further elucidation of the role of genetic variants underlying IgAN, and hologenetic views of gene variants and environmental factors, would be necessary to understand the precise pathogenic mechanism of IgAN in more detail.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738–48.

    Article  CAS  PubMed  Google Scholar 

  2. Glassock RJ, Kurokawa K, Yoshida M, Sakai O, Okada M, Shigematsu H, et al. IgA nephropathy in Japan. Am J Nephrol. 1985;5:127–37.

    Article  CAS  PubMed  Google Scholar 

  3. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, et al. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee report for 2009 and 2010. Clin Exp Nephrol. 2013;17:155–73.

    Article  PubMed  Google Scholar 

  4. D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.

    PubMed  Google Scholar 

  5. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–7.

    Article  CAS  PubMed  Google Scholar 

  6. Wyatt RJ, Julian BA, Baehler RW, Stafford CC, McMorrow RG, Ferguson T, et al. Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. Central Kentucky Region of the Southeastern United States IgA Nephropathy DATABANK Project. J Am Soc Nephrol. 1998;9:853–8.

    CAS  PubMed  Google Scholar 

  7. Sehic AM, Gaber LW, Roy 3rd S, Miller PM, Kritchevsky SB, Wyatt RJ. Increased recognition of IgA nephropathy in African-American children. Pediatr Nephrol. 1997;11:435–7.

    Article  CAS  PubMed  Google Scholar 

  8. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8, e1002765.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 2003;63:2286–94.

    Article  PubMed  Google Scholar 

  10. Cosyns JP, Malaise J, Hanique G, Mourad M, Baldi A, Goebbels RM, et al. Lesions in donor kidneys: nature, incidence, and influence on graft function. Transpl Int. 1998;11:22–7.

    Article  CAS  PubMed  Google Scholar 

  11. Rosenberg HG, Martinez PS, Vaccarezza AS, Martinez LV. Morphological findings in 70 kidneys of living donors for renal transplant. Pathol Res Pract. 1990;186:619–24.

    Article  CAS  PubMed  Google Scholar 

  12. Waldherr R, Rambausek M, Duncker WD, Ritz E. Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant. 1989;4:943–6.

    CAS  PubMed  Google Scholar 

  13. Beerman I, Novak J, Wyatt RJ, Julian BA, Gharavi AG. The genetics of IgA nephropathy. Nat Clin Pract Nephrol. 2007;3:325–38.

    Article  CAS  PubMed  Google Scholar 

  14. Karnib HH, Sanna-Cherchi S, Zalloua PA, Medawar W, D’Agati VD, Lifton RP, et al. Characterization of a large Lebanese family segregating IgA nephropathy. Nephrol Dial Transpl. 2007;22:772–7.

    Article  CAS  Google Scholar 

  15. Rambausek M, Hartz G, Waldherr R, Andrassy K, Ritz E. Familial glomerulonephritis. Pediatr Nephrol. 1987;1:416–8.

    Article  CAS  PubMed  Google Scholar 

  16. Scolari F, Amoroso A, Savoldi S, Mazzola G, Prati E, Valzorio B, et al. Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis. 1999;33:857–65.

    Article  CAS  PubMed  Google Scholar 

  17. Wakai K, Kawamura T, Matsuo S, Hotta N, Ohno Y. Risk factors for IgA nephropathy: a case-control study in Japan. Am J Kidney Dis. 1999;33:738–45.

    Article  CAS  PubMed  Google Scholar 

  18. Miyagawa S, Dohi K, Hanatani M, Yamanaka F, Okuchi T, Sakamoto K, et al. Anaphylactoid purpura and familial IgA nephropathy. Am J Med. 1989;86:340–2.

    Article  CAS  PubMed  Google Scholar 

  19. Frasca GM, Soverini L, Gharavi AG, Lifton RP, Canova C, Preda P, et al. Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol. 2004;17:778–85.

    PubMed  Google Scholar 

  20. Suzuki S, Suzuki Y, Kobayashi Y, Harada T, Kawamura T, Yoshida H, et al. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy. Am J Kidney Dis. 2000;35:896–903.

    Article  CAS  PubMed  Google Scholar 

  21. Schena FP, D’Altri C, Cerullo G, Manno C, Gesualdo L. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis. Kidney Int. 2001;60:732–40.

    Article  CAS  PubMed  Google Scholar 

  22. Goto S, Narita I, Saito N, Watanabe Y, Yamazaki H, Sakatsume M, et al. A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int. 2002;62:980–5.

    Article  CAS  PubMed  Google Scholar 

  23. Narita I, Goto S, Saito N, Song J, Omori K, Kondo D, et al. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int. 2003;64:1050–8.

    Article  CAS  PubMed  Google Scholar 

  24. Narita I, Goto S, Saito N, Song J, Ajiro J, Sato F, et al. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension. 2003;42:304–9.

    Article  CAS  PubMed  Google Scholar 

  25. Song J, Narita I, Goto S, Saito N, Omori K, Sato F, et al. Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy. J Med Genet. 2003;40:372–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sato F, Narita I, Goto S, Kondo D, Saito N, Ajiro J, et al. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens. 2004;64:35–42.

    Article  CAS  PubMed  Google Scholar 

  27. Feehally J, Farrall M, Boland A, Gale DP, Gut I, Heath S, et al. HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol. 2010;21:1791–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43:321–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, et al. A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet. 2012;44:178–82.

    Article  CAS  Google Scholar 

  30. Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014;46:1187–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Li M, Foo JN, Wang JQ, Low HQ, Tang XQ, Toh KY, et al. Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun. 2015;6:7270.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 2008;19:1008–14.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, Ghiggeri GM, et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet. 2000;26:354–7.

    Article  CAS  PubMed  Google Scholar 

  35. Bisceglia L, Cerullo G, Forabosco P, Torres DD, Scolari F, Di Perna M, et al. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Human Genet. 2006;79:1130–4.

    Article  CAS  Google Scholar 

  36. Paterson AD, Liu XQ, Wang K, Magistroni R, Song X, Kappel J, et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol. 2007;18:2408–15.

    Article  CAS  PubMed  Google Scholar 

  37. Milillo A, La Carpia F, Costanzi S, D’Urbano V, Martini M, Lanuti P, et al. A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. Eur J Hum Genet: EJHG. 2015

    Google Scholar 

  38. Liu R, Hu B, Li Q, Jing X, Zhong C, Chang Y et al. Novel genes and variants associated with IgA nephropathy by co-segregating with the disease phenotypes in 10 IgAN families. Gene 2015.

    Google Scholar 

Download references

Acknowledgment

This work was partly supported by Grant-in-Aid for Scientific Research (B) to I. Narita and (C) to S. Goto from the Japan Society for the Promotion of Science and also by MEXT KAKENHI (221S0002).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ichiei Narita .

Editor information

Editors and Affiliations

Additional information

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Narita, I. et al. (2016). Is IgA Nephropathy (IgAN) a Familial or Sporadic Disease?. In: Tomino, Y. (eds) Pathogenesis and Treatment in IgA Nephropathy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55588-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55588-9_3

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55587-2

  • Online ISBN: 978-4-431-55588-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics